From Alphastreet - Earnings Decoded. Market Intelligence Delivered · AlphaStreet Newsdesk · · 1m 10s
BIO-key International Q3 2026 Earnings Miss
BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises.
In brief
BIO-key International's Q3 2026 earnings miss hides operational progress as stock rises. BIO-key International reported a $4.01 per share loss in Q3 2026, missing analyst estimates, but stock rose 4.0% to $2.58 as investors saw margin improvements from software licensing. Originally reported by Alphastreet - Earnings…
Q3 2026 Earnings Results
BIO-key International reported an EPS loss of $4.01 per share in Q3 2026, missing analyst estimates of a $0.35 loss.
Revenue and Stock Performance
Revenue fell to $1.5M from $2.4M estimates, but stock rose 4.0% to $2.58.
Margin Expansion Story

Gross margin expanded to 89.3% from 77% a year ago, driven by software license revenue growth.
“license fee revenue grew 39% year over year, and that high-margin recurring revenue lifted our gross margin to 90%, from 77% a year ago and helped reduce our operating loss by 8%”
Revenue Composition Shift
Software license fee revenue grew 39.0%, offsetting lower hardware sales despite a 4.3% year-over-year revenue decline.
Sequential Deterioration
Revenue declined from $2.1M in Q1 2026 to $1.5M in Q3 2026, with EPS collapsing from $0.15 to $4.01 loss.
Q1 2027 Inflection Point

Management targets profitability by Q1 2027 with $1.2 million in annual license fee renewals.
“We expect roughly $1.2 million in annual license fee renewals in the first quarter alone, and we are targeting profitability as we approach that timeframe”
Market Reaction
Stock rose 4.0% despite earnings miss, signaling investor confidence in margin improvements and Q1 2027 renewal cycle.
The headline
BIO-key International reported a $4.01 per share loss in Q3 2026, missing analyst estimates, but stock rose 4.0% to $2.58 as investors saw margin improvements from software licensing.
Read the TL;DR — this story on one card.





